Industry leaders and experts envisage positive change in the biopharma sector over the coming year, fueled by advances in science and data processing. The application of artificial intelligence will improve and make more efficient activities across the business continuum, from drug discovery to manufacturing, while genomics will offer even more fruitful avenues for the development […]

A drug is showing promising results in treating critical COVID-19 patients who are suffering from respiratory failure. Dr. Jonathan Javitt, the CEO Of NeuroRx, said they are encouraged by the results they’ve seen so far in the study of Zyesami. “So, we’re at the point we’ve got initial results from a 196-person study,” Javitt said […]

On Dec. 3, 2020, six biopharma executives joined Pharmaceutical Executive to discuss diversity and inclusion (D&I) in the industry. Michael J. Hennessy Jr., president and CEO of MJH Life Sciences, parent company of Pharmaceutical Executive, welcomed the panel to the closed virtual roundtable. He commented on the racial unrest of 2020 that brought this topic […]